000			02078 a2200541 4500
005			20250517103505.0
264		0	_c20180202
008			201802s 0 0 eng d
022			_a1557-3265
024	7		_a10.1158/1078-0432.CCR-16-0529 _2doi
040			_aNLM _beng _cNLM
100	1		_aZook, Phillip
245	0	0	_aCombination of Imatinib Mesylate and AKT Inhibitor Provides Synergistic Effects in Preclinical Study of Gastrointestinal Stromal Tumor. _h[electronic resource]
260			_bClinical cancer research : an official journal of the American Association for Cancer Research _cJan 2017
300			_a171-180 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aDisease Models, Animal
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aDrug Synergism
650	0	4	_aGastrointestinal Stromal Tumors _xdrug therapy
650	0	4	_aGene Expression Profiling
650	0	4	_aHeterocyclic Compounds, 3-Ring _xpharmacology
650	0	4	_aHumans
650	0	4	_aImatinib Mesylate _xpharmacology
650	0	4	_aMice
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aProto-Oncogene Proteins c-kit _xantagonists & inhibitors
650	0	4	_aSignal Transduction
650	0	4	_aSurvival Analysis
650	0	4	_aTumor Burden _xdrug effects
650	0	4	_aExome Sequencing
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aPathak, Harsh B
700	1		_aBelinsky, Martin G
700	1		_aGersz, Lawrence
700	1		_aDevarajan, Karthik
700	1		_aZhou, Yan
700	1		_aGodwin, Andrew K
700	1		_avon Mehren, Margaret
700	1		_aRink, Lori
773	0		_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 23 _gno. 1 _gp. 171-180
856	4	0	_uhttps://doi.org/10.1158/1078-0432.CCR-16-0529 _zAvailable from publisher's website
999			_c26183560 _d26183560